IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA
NCT02830009 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2016-07-13
Summary
The aim of this study is to know the difference between protein profiles (multi-analyte profile) of PH1 patients, idiopathic hypercalciuria (IH) patients and PH1 patients 'siblings. Idiopathic hypercalciuria is a less severe kidney disease that PH1, which also leads to the formation of kidney stones.
The aim is to identify patterns of discriminating markers associated with primary hyperoxaluria type 1 (PH1) that will significantly improve clinical diagnosis and prognosis.
Conditions
- Primary Hyperoxaluria Type 1
- Idiopathic Hypercalciuria
Interventions
- OTHER
-
Urines samples
24-hour urines will be collected
- OTHER
-
Blood sample
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2013-07-31
- Completion
- 2015-12-31
Countries
- France
More Related Trials
-
Effect of Active Vitamin D and Etelcalcetide on Human Osteoclasts in Patients With Chronic Kidney Disease
NCT03527511 ·Status: COMPLETED
-
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
NCT01725113 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
NCT06892301 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Analysis of Calcium Balance in Chronic Kidney Disease
NCT00974532 ·Status: COMPLETED ·Phase: NA
-
Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease
NCT00995163 ·Status: COMPLETED
-
Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
NCT00280215 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparison of DASH With Oxalate Restricted Diet on Urine in Recurrent Stone Formers With Hyperoxaluria
NCT01650935 ·Status: COMPLETED ·Phase: NA
-
Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
NCT01341782 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of Urine Composition Saturation and Dietary Intervention in Subjects Without Urinary Calculi
NCT05102279 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Adherence to the Mediterranean Diet in Patients with Recurrent Renal Stones and Disease Osteometabolic
NCT06869603 ·Status: RECRUITING
-
Biomarkers and Event Patterns of Vascular Disease in Hemodialysis
NCT07170761 ·Status: ACTIVE_NOT_RECRUITING
-
Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet
NCT04651088 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
NCT00664430 ·Status: TERMINATED ·Phase: PHASE4
-
Plasma Oxalate in Patient With Short Bowel
NCT04119765 ·Status: COMPLETED
-
Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism
NCT00990704 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacoepidemiological Study of Secondary Hyperparathyroidism in Lorraine
NCT02888639 ·Status: COMPLETED
-
Low Salt Diet in Idiopathic Hypercalciuria
NCT01005082 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Parathyroid Hyperplasia in Patients With Chronic Kidney Disease.
NCT03182517 ·Status: UNKNOWN
-
Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving Hemodialysis
NCT00667576 ·Status: COMPLETED ·Phase: PHASE2
-
FGF-23 and PTH in Hemodialysis Patients
NCT04350944 ·Status: COMPLETED
-
Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism
NCT00307840 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Low Protein Diet Supplemented With Ketoanalogues Supplementation on Uremic Toxins Production
NCT03959228 ·Status: UNKNOWN ·Phase: PHASE3
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
NCT06989320 ·Status: RECRUITING ·Phase: NA
-
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones
NCT02503345 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria
NCT00490113 ·Status: WITHDRAWN ·Phase: PHASE2